LD-2 disclosure · 1st Quarter - Report
MYLAN LABORATORIES
Client
- Location
- West Virginia · United States of America
Registrant
- Description
- Law Firm
- Location
- WASHINGTON, District of Columbia, United States of America
Lobbying activities
3 issuesPharmacy
H.R. 759, Food and Drug Administration Globalization Act H.R. 573, Bill to prohibit authorized generics during period of exclusivity S. 501, Fair Prescription Drug Competition Act
Lobbyistsms REGINA MARIA SHERICK · ms STEPHANIE A KENNAN · MARK RAYDER · LAURA HOLLAND
Covered position (ms REGINA MARIA SHERICK): Staff Assistant, Senate Finance Committee
Covered position (LAURA HOLLAND): Legislative Aide to Rep. Nathan Deal (GA)
TargetedSENATE · HOUSE OF REPRESENTATIVES · Health & Human Services, Dept of (HHS) · Centers For Medicare and Medicaid Services (CMS)
Copyright/Patent/Trademark
H.R. 1706, Protecting Consumer Access to Generic Drugs Act
Lobbyistsms REGINA MARIA SHERICK · ms STEPHANIE A KENNAN · MARK RAYDER · LAURA HOLLAND
Covered position (ms REGINA MARIA SHERICK): Staff Assistant, Senate Finance Committee
Covered position (LAURA HOLLAND): Legislative Aide to Rep. Nathan Deal (GA)
TargetedSENATE · HOUSE OF REPRESENTATIVES · Health & Human Services, Dept of (HHS) · Centers For Medicare and Medicaid Services (CMS)